Pulmatrix Q3 EPS $(1.03) Beats $(1.05) Estimate, Sales $1.75M Miss $1.86M Estimate
Portfolio Pulse from Benzinga Newsdesk
Pulmatrix reported Q3 losses of $(1.03) per share, beating the analyst consensus estimate of $(1.05) by 1.9 percent. However, the company's quarterly sales of $1.75 million missed the analyst consensus estimate of $1.86 million by 5.75 percent.
November 09, 2023 | 2:14 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Pulmatrix's Q3 earnings beat estimates but sales missed, which could lead to mixed market reactions.
Pulmatrix's Q3 earnings beat estimates, which is positive for the stock. However, the company's sales missed estimates, which is negative. The mixed results could lead to uncertain market reactions in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100